Tech Company Financing Transactions
Epigenic Therapeutics Funding Round
Epigenic Therapeutics, based in Shanghai, secured $60 million in funding from Lapam Capital, OrbiMed and Qiming Venture Partners USA.
Transaction Overview
Company Name
Announced On
9/8/2025
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the advancement of multiple preclinical programs and further enhance its technology platforms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Floor 5&6, Unit 1, Building 4, 160 Basheng Road, Pilot Free
Shanghai, Undisclosed
CN
Shanghai, Undisclosed
CN
Phone
Undisclosed
Website
Email Address
Overview
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing thera utilizing regulation of epigenetic genome for a variety of diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bob Zhang
Browse more venture capital transactions:
Prev: 9/8/2025: DataCrunch venture capital transaction
Next: 9/8/2025: Unrivaled Basketball venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs